FERTIN Trademark
FERTIN is a USPTO trademark filed by Fertin Pharma A/S. Status: Pending.
Trademark Facts
| Mark | FERTIN |
|---|---|
| Serial Number | 99527265 |
| Status | Pending |
| Filing Date | 2025-12-03 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 040 (Material Treatment), 042 (Software & IT) |
| Owner | Fertin Pharma A/S |
| Attorney of Record | Tamar Niv Bessinger |
| Prosecution Events | 8 |
| Latest Event | CNRT on 2026-05-05 |
Goods & Services
Class 005: Pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; pharmaceutical preparations for smoking cessation; aerosolized or inhaled therapeutics and pharmaceuticals; drug delivery agents in the form of fast liquefiable tablets, compressed gum, extruded gum, lozenges, pouch powder, dissolvable films, coatings for tablets, and transdermal patches that facilitate the delivery of pharmaceutical preparations; vitamins and dietary supplements; nicotine chewing gum; nicotine gum for use as an aid to stop smoking; Class 040: Custom manufacturing services for pharmaceuticals and nutraceuticals; contract manufacturing services for pharmaceuticals and nutraceuticals; processing of pharmaceutical preparations; processing of nutraceutical preparations; formulation services for pharmaceuticals and nutraceuticals; blending, granulation, encapsulation, tableting, and coating of pharmaceuticals and nutraceuticals; sterilization services for pharmaceutical products; lyophilization (freeze-drying) services; custom synthesis and purification of active pharmaceutical ingredients (APIs) and nutraceutical ingredients; packaging and labeling services for pharmaceuticals and nutraceuticals; advisory and consultancy services relating to the aforesaid; Class 042: Research and development services for pharmaceuticals and nutraceuticals formulation, research, and development of pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems; formulation, research, and development of pharmaceuticals for smoking cessation; provision of advice; analytical testing and quality control services; stability testing; laboratory services for pharmaceuticals and nutraceuticals; consultancy in the field of pharmaceutical and nutraceutical research; design and development of drug delivery systems; advisory and consultancy services relating to the aforesaid
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-05-05 | Notice of Non-Final Office Action | NFO |
| 2026-05-05 | Non-Final Action | NFIN |
USPTO Refusals on Record
- foreign_registration_required
- indefinite_identification
- multiple_class_application